Results 141 to 150 of about 147,676 (314)
DESIGN AND DEVELOPMENT OF TELMISARTAN-LOADED LIPOSOMES USING THIN LAYER HYDRATION METHOD
openalex +1 more source
cDC1 Subtype‐Specific In Vivo Targeting of Liposomes
Dendritic cells, particularly the cDC1 subtype, offer a promising target for drug delivery via liposomes due to their pivotal role in immune regulation, allowing for amplified therapeutic responses. Herein, we show an integration of physicochemical characterization and cell experiments to achieve effective in vivo cDC1 targeting through anti‐CLEC9A ...
Maximilian Schaaf +11 more
wiley +1 more source
Charge Effects: Influence of Surface Charge on Protein Corona Adsorption Behavior on Liposomal Formulations. [PDF]
Chen Q +7 more
europepmc +1 more source
Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong +5 more
wiley +1 more source
Surface-Attached Model Lipid Membranes Derived from Human Red Blood Cells. [PDF]
Mudakannavar SP +3 more
europepmc +1 more source
Electrospun amphiphilic nanofibers for the in situ preparation and delivery of drug-loaded liposomes
Irja Alainezhad Kjærvik
openalex +1 more source
Targeting DNA‐LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity
Attaching antibodies against endothelial cell surface proteins redirects the delivery and expression of DNA‐lipid nanoparticles to organs of interest. Our targeted nanoparticles enable organ‐selective DNA expression in the endothelium of the lungs, brain, or spleen, providing a therapeutic platform for dozens of endothelial‐centric diseases.
Nicolas Marzolini +24 more
wiley +1 more source
Cryopreservation technology for improving the stability of liposomes and its precise drug monitoring in clinical drug research. [PDF]
Boafo GF +9 more
europepmc +1 more source

